Microsoft’s commitment to compliance in pharma and life sciences
Over a year has gone by since the beginning of the global pandemic, and it’s clear that the pharmaceutical industry and COVID-19 vaccines are at the center of everyone’s attention. Calls for quick and rigorous development of a COVID-19 vaccine have given way to the equally important demand for rapid distribution.
Because of this unprecedented situation, there’s been incredible pressure to support and manage a large data infrastructure to help administer and trace the distribution as well as how the vaccines work. Even long-standing cold chain technologies used to store vaccine doses are transforming under changing requirements for connectivity, access, and security compliance. The need for analytics, high-capacity storage, and increased computing power has expanded the need for data handling, analytics tools, and applications that only the cloud can support.